⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8573530 | 0.81 | SIGMAR1 (0.31) | — | |
| SCHEMBL28404896 | 0.77 | — | — | |
| SCHEMBL9118151 | 0.77 | — | — | |
| SCHEMBL12002902 | 0.77 | — | — | |
| SCHEMBL31548667 | 0.77 | — | — | |
| SCHEMBL444986 | 0.77 | — | — | |
| SCHEMBL25180021 | 0.76 | — | — | |
| SCHEMBL11095961 | 0.75 | — | — | |
| SCHEMBL638552 | 0.75 | OPRM1 (0.39) | — | |
| SCHEMBL10864423 | 0.74 | CAD (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115362203-B | Moisture-curable non-yellowing clear compositions and methods of making the same | 迈图高新材料公司 | 2024-07-16 | — | — | CN | disclosed |
| US-20230106223-A1 | MOISTURE-CURABLE NON-YELLOWING CLEAR COMPOSITION AND METHOD OF MAKING THEREOFROM | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-04-06 | — | — | US | disclosed |
| CN-115362203-A | Moisture-curable non-yellowing clear composition and preparation method thereof | 迈图高新材料公司 | 2022-11-18 | — | — | CN | disclosed |
| EP-4081585-A1 | MOISTURE-CURABLE NON-YELLOWING CLEAR COMPOSITION AND METHOD OF MAKING THEREOFROM | Momentive Performance Materials Inc. (US) | 2022-11-02 | — | — | EP | disclosed |
| WO-2021158370-A1 | MOISTURE-CURABLE NON-YELLOWING CLEAR COMPOSITION AND METHOD OF MAKING THEREOFROM | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2021-08-12 | — | — | WO | disclosed |